Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
02/2002
02/07/2002US20020016363 Novel anticancer compounds : process for their preparation and pharmaceutical compositions containing them
02/07/2002US20020016356 Antitumor agents
02/06/2002EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands
02/06/2002EP1177177A1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
02/05/2002US6344570 Substituted urea derivatives as cell adhesion inhibitors
02/05/2002US6344463 Skin disorders, acne
01/2002
01/31/2002WO2002008221A2 Capsaicin receptor ligands
01/31/2002WO2002008217A2 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS
01/31/2002WO2002008200A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
01/31/2002US20020013360 Protease inhibitors
01/31/2002US20020013346 C7 ester substituted taxanes
01/31/2002CA2415606A1 Capsaicin receptor ligands
01/30/2002EP1175414A1 Taxane formulations having improved solubility
01/30/2002CN1333770A Novel dicyclic compound
01/30/2002CN1333764A Benzofuran derivatives, process for the preparation of the same and uses thereof
01/24/2002WO2002006276A1 Beta3 adrenergic agonists
01/24/2002US20020010206 Treating cyclooxygenase-2 mediated disorders.
01/24/2002US20020009650 High electroconductivity
01/24/2002CA2415331A1 Beta3 adrenergic agonists
01/23/2002EP1173429A1 Protease inhibitors
01/23/2002CN1332737A Thrombin inhibitors
01/23/2002CN1078210C Watersoluble azole antifungals
01/22/2002US6340766 Photochromic dyes on substrates like glass with protective coatings
01/22/2002US6340694 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
01/17/2002WO2002004440A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
01/17/2002US20020007078 2H-naphtho(1,2-b)pyrans with a cycloalkyl ester substituent at the 5-position; improved solubility in polymeric matrices used as carriers in imbibition processes; neutral-colored photochromic articles e.g., lenses, windows; less defects
01/17/2002DE10031809A1 Neue Flavonoide und ihre Verwendung in kosmetischen und dermatologischen Zubereitungen New flavonoids and their use in cosmetic and dermatological preparations
01/17/2002CA2413044A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
01/16/2002CN1331680A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors
01/15/2002US6339164 C2 substituted phenyl taxane derivatives and pharmaceutical compositions containing them
01/10/2002WO2002002566A1 Therapeutic compounds and methods
01/10/2002US20020004513 Azacyclic compounds
01/09/2002EP1170288A2 Diphenylureum derivatives and their use as alpha2/5-HT2c antagonists
01/09/2002EP1169294A2 Pharmaceutical compounds
01/08/2002CA2204179C Novel photochromic indeno-fused naphthopyrans
01/03/2002WO2001062233A3 Adenosine receptor modulators
01/03/2002US20020002292 C7 taxane derivatives and pharmaceutical compositions containing them
01/03/2002US20020002284 Processes and novel intermediates for 11-oxa prostaglandin synthesis
01/02/2002EP1165553A1 C10 ester substituted taxanes as antitumor agents
01/02/2002EP1165552A1 C7 carbonate substituted taxanes as antitumor agents
01/02/2002EP1165551A1 C10 carbamoyloxy substituted taxanes as antitumor agents
01/02/2002EP1165550A1 C10 carbonate substituted taxanes as antitumor agents
01/02/2002EP1165549A1 C7 carbamoyloxy substituted taxanes as antitumor agents
01/02/2002EP1165068A1 C10 heterosubstituted acetate taxanes as antitumor agents
01/02/2002EP0825189B1 1,4-benzodioxin derivatives
01/02/2002CN1329617A Hygromycin A derivatives as antibacterial agents
01/02/2002CN1329608A Alpha-methylbenzyl-containing thioure a inhibitors of herpes viruses containing phenylenediamine group
01/02/2002CN1329607A Substituted benzopyran analogs for treatment of inflammation
01/02/2002CN1329605A Benzofuran derivatives their preparation and use
01/02/2002CN1077105C Optically active bis-methyldixane derivatives
01/01/2002US6335362 Antitumor and anticarcinogenic agents for leukemia
12/2001
12/27/2001WO2001098248A2 Hiv integrase inhibitors
12/27/2001US20010056117 Oxygen-containing heterocyclic compounds
12/27/2001US20010056100 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases
12/27/2001CA2412985A1 Hiv integrase inhibitors
12/26/2001CN1328455A Use of N-substituted azabicycloalkane derivatives for treating diseases of central nervous system
12/25/2001US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation
12/25/2001US6333324 For therapy and prophylaxis of matrix metalloproteinases (mmp) or tumor necrosis factor .alpha. (tnf.alpha.), mediated diseases
12/22/2001CA2312252A1 5,6,7-trinor-4, 8-inter-m-phenylene pgi2 derivative and medicine containing the same
12/20/2001WO2001096302A1 Piperidines for use as orexin receptor antagonists
12/20/2001WO2001096283A2 Hiv integrase inhibitors
12/20/2001WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents
12/20/2001CA2412857A1 Hiv integrase inhibitors
12/19/2001EP1163251A1 N-acylphosphoramidites and their use in oligonucleotide synthesis
12/18/2001US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
12/13/2001US20010051640 C7 carbamoyloxy substituted taxanes
12/12/2001EP1162201A2 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
12/12/2001EP1161237A1 Protease inhibitors
12/12/2001CN1326450A Hydroxyflavone derivatives as tau protein kinase inhibitors
12/12/2001CN1076022C Cycloether compounds as sodium channel regulating agent
12/11/2001US6329534 Useful for therapy of type ii diabetes, obesity, hyperglycemia, inadequate glucose clearance, hyperinsulinemia, hypertriglyceridemia, and high-circulating glucocorticoid levels
12/11/2001US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same
12/06/2001WO2001092563A2 Method for detecting a detectable product
12/06/2001WO2001092280A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections
12/06/2001WO2001092188A1 Method for labeling with tritium
12/06/2001WO2001046178A3 Substituierte bisindolymaleimide
12/06/2001CA2411315A1 Method for detecting a detectable product
12/06/2001CA2410643A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections
12/05/2001EP1159276A2 Benzofuran-2-ones as colorants for organic materials
12/05/2001EP1017690B1 Novel aromatic substituted naphthopyrans
12/05/2001EP0828724B1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
12/05/2001EP0745075B1 6-substituted mycophenolic and derivatives with immunosuppressive activity
12/05/2001EP0745071B1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity
12/05/2001EP0693065B1 Non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
11/2001
11/29/2001WO2001028996A3 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/28/2001EP0690712B1 Taxanes having a pyridyl substituted side-chain
11/28/2001CN1323797A Chinese chestnut flower flavone compound and its extraction process
11/28/2001CN1323794A Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites
11/27/2001US6323238 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
11/27/2001US6323235 Benzene-condensed heterocyclic derivatives and their uses
11/27/2001US6323217 Cardiovascular disorders
11/22/2001WO2001087876A1 Sialic acid derivatives
11/22/2001WO2001087870A1 Hydroxamic acid derivatives
11/22/2001WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001US20010044547 From l-mannonic-gamma-lactone intermediates; for prophylaxis of HIV/AIDS HIV
11/22/2001US20010044529 Deprotecting an oligonucleotide by heating in a fluid, where the phosphorus atom is O-protected with a thermolabile group such as (pyrrolidin-1-one-1-yl)alkyl; synthesis of oligonucleotides
11/22/2001CA2409035A1 Hydroxamic acid derivatives
11/22/2001CA2408849A1 Cyclohexane derivatives and their use as therapeutic agents
11/21/2001CN1323301A Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
11/21/2001CN1075066C Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 120